Search for: "Weeks v. Weeks" Results 5241 - 5260 of 67,005
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Aug 2022, 9:09 am by Eric Goldman
[Note: the filing was just unsealed this week] Prior Coverage of hiQ v. [read post]
25 Aug 2022, 8:13 am by Zalkind Duncan & Bernstein LLP
Last week the Fourth Circuit Court of Appeals held that individuals who experience gender dysphoria can be protected from discrimination under the Americans with Disabilities Act (ADA) and the Rehabilitation Act. [read post]
25 Aug 2022, 4:57 am by Zak Gowen
The second noteworthy decision came less than two weeks later, when—in what may yet lead to an interesting postscript—the Court of Justice of the European Union (“CJEU”) handed down judgment in Volvo AB (publ.) and DAF Trucks NV v RM, C-267/20, EU:C:2022:494, another cartel damages case raising limitation issues. [read post]
25 Aug 2022, 2:04 am by Giorgio Luceri
In case you missed it, here is an overview of the posts from the last few weeks. [read post]
It is still unclear whether the investigation will result in an enforcement action.[15] Other Financial Regulatory Agencies Beyond the SEC, other financial regulatory agencies have clearly signaled to the market that they intend to step up ESG regulation and enforcement: Approximately two weeks after the SEC announced its creation of the Climate and ESG Task force, the Commodity Futures Trading Commission (“CFTC”) established its own Climate Risk Unit “to support the… [read post]
24 Aug 2022, 4:00 am by Administrator
For this last week, the most-consulted three English-language decisions were: 1. [read post]
22 Aug 2022, 12:06 pm by Richard Hunt
She was denied her hormone therapy for at least two weeks and only received it irregularly after that. [read post]
22 Aug 2022, 11:09 am by Anna Bower
In a court filing prior to the hearing, Ellis’s legal team had pointed to Georgia Court of Appeals precedent in Kenerly v. [read post]
22 Aug 2022, 9:15 am by Eileen McDermott
Last week, the Electronic Frontier Foundation (EFF) announced that it is launching a campaign against Senator Thom Tillis’ (R-NC) proposed “Patent Eligibility Restoration Act of 2022,” which would effectively abrogate the Supreme Court’s decisions in Ass’n for Molecular Pathology v. [read post]